🇺🇸 FDA

Intelligence Platform

Patents

Browse 38 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9861614

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856241

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9738624

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9714226

Hydrazide containing nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9585874

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9550757

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9428490

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9303000

Olefin containing nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9266843

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9206158

Hydrazide containing nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9096543

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9079865

Hydrazide containing nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999996

Hydrazide containing nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513230

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted